BIRC5 and cancer: Survivin, the smallest member of the mammalian inhibitors of the apoptosis protein (IAP) family [17,18], is upregulated in various malignancies to protect cells from apoptosis [18,19], which justifies its role as a rational target for cancer therapy [20].